Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - octyl salicylate, quantity: 50 mg/g; octocrylene, quantity: 50 mg/g; homosalate, quantity: 100 mg/g; butyl methoxydibenzoylmethane, quantity: 40 mg/g; 4-methylbenzylidene camphor, quantity: 40 mg/g - stick - excipient ingredients: saccharin; liquid paraffin; ceresin; dl-alpha-tocopheryl acetate; menthol; caprylic/capric/stearic triglyceride; fragrance (perfume); colloidal anhydrous silica; microcrystalline wax; pvp/eicosene copolymer; synthetic wax; coconut oil; aloe vera - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

dpp pharmaceuticals pty ltd - homosalate, quantity: 100 mg/g; octocrylene, quantity: 50 mg/g; octyl salicylate, quantity: 50 mg/g; butyl methoxydibenzoylmethane, quantity: 40 mg/g; 4-methylbenzylidene camphor, quantity: 40 mg/g - stick - excipient ingredients: dl-alpha-tocopheryl acetate; ceresin; liquid paraffin; goat milk; menthol; saccharin; medium chain triglycerides; fragrance (perfume); coconut oil; aloe vera; colloidal anhydrous silica; microcrystalline wax; pvp/eicosene copolymer; synthetic wax - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

United States - English - NLM (National Library of Medicine)

promius pharma, llc - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.5 mg in 1 g - trianex ® 0.05% ( triamcinolone acetonide ointment, usp ) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. trianex ® 0.05% ( triamcinolone acetonide ointment, usp ) is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

rochester pharmaceuticals - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - hydrocortisone acetate 10 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. pediatric patients may demonstrate greater susceptibility to topical corticosteroid induced hpa axis suppression and cushing’s syndrome than mature patients because of a larger skin surface area to body weight ratio.  hypothalamic-pituitary-adrenal (hpa) axis suppression, cushing’s syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema.  administration of topical corticosteroids to children should

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 0.1 mg in 1 g - estradiol vaginal cream 0.01% is indicated in the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. estradiol vaginal cream 0.01% should not be used in women with any of the following conditions:

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 0.1 mg in 1 g - estradiol vaginal cream, 0.01% is indicated in the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. estradiol vaginal cream, 0.01% should not be used in women with any of the following conditions: 1. undiagnosed abnormal genital bleeding. 2. known, suspected, or history of cancer of the breast. 3. known or suspected estrogen-dependent neoplasia. 4. active dvt, pe or history of these conditions. 5. active arterial thromboembolic disease (for example, stroke, mi) or a history of these conditions. 6. known anaphylactic reaction or angioedema to estradiol vaginal cream, 0.01%. 7. known liver dysfunction or disease. 8. known protein c, protein s, or antithrombin deficiency, or other known thrombophilic disorders. 9. known or suspected pregnancy.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

artesan pharma gmbh & co. kg - enalapril (enalapril maleate), hydrochlorothiazide - tablets - 20mg+12,5mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

advance pharma gmbh - pantoprazole (pantoprazole sodium sesquihydrate) - tablets gastro-resistant - 40mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

artesan pharma gmbh & co. kg - carvedilol - tablets - 6,25mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

artesan pharma gmbh & co. kg - carvedilol - tablets - 25mg